• Milk-Derived EV Uptake in Intestinal Organoids

  2026-09-22

  This study develops three porcine intestinal stem cell-based models to examine how milk-derived extracellular vesicles are taken up across epithelial surfaces and how they affect intestinal stemness and differentiation. Its main advance is the integration of anatomical region, epithelial polarity, and endocytosis inhibition, providing a more physiologically relevant framework than conventional intestinal cell lines.

• Viral RIPK3 Degradation and Proteasome-Linked Inflammation

  2026-09-22

  Liu and colleagues identified a viral inducer of RIPK3 degradation (vIRD) that recruits host SCF machinery to drive ubiquitination and proteasome-dependent loss of RIPK3, suppressing necroptosis while promoting orthopoxvirus replication and disease. The study connects viral immune evasion with pathogen–host evolution and provides a useful framework for testing proteasome-dependent regulation of inflammatory cell death.

• Primidone and PON1: Insights from an AED Study

  2026-09-21

  The reference study established a comparative in vitro framework for testing antiepileptic drugs against human serum paraoxonase 1 (hPON1). Primidone inhibited hPON1 noncompetitively, providing a biochemical safety and mechanism-of-action context that should be distinguished from its better-known neuronal and kinase-related research applications.

• Cassava A20/AN1 Genes Under Multiple Stresses

  2026-09-21

  Chen and colleagues functionally characterized cassava Metip4, Metip8, and Metip11, showing shared positive effects on tolerance to drought, salinity, temperature extremes, and manganese stress, alongside gene-specific responses to cadmium and copper. The study combines plant transformation, virus-induced gene silencing, physiological measurements, protein localization, interaction testing, and transcriptomics to distinguish broad functional convergence from stress-specific regulation.

• GLT-1, CB1-CREB Signaling, and TBI Recovery

  2026-09-20

  A 2025 Biomolecules study identifies a mechanistic link between post-traumatic 2-AG elevation, CB1-CREB signaling, reduced astrocytic GLT-1, and glutamate-related neuronal injury. Using controlled cortical impact, pharmacological intervention, behavioral testing, and molecular assays, the authors show that restoring GLT-1 or blocking CB1-associated signaling may protect cognition and neurons after traumatic brain injury.

• Bestatin, Actinonin, and Intracellular Drug Retention

  2026-09-19

  This 2002 study separated cell-surface aminopeptidase inhibition from antiproliferative activity by combining leukemia-cell assays with pharmacological modulation of MRP and P-glycoprotein drug efflux. Its central contribution is the evidence that bestatin and actinonin depend substantially on intracellular exposure, while verapamil functions primarily as a transporter-interaction probe rather than proof that calcium-channel blockade causes growth inhibition.

• Chloroquine Diphosphate in AML Assays

  2026-09-18

  Build more informative autophagy, chemotherapy-sensitization, and AML ferroptosis workflows with a water-soluble research reagent. This guide separates direct product evidence from exploratory links between autophagy modulation and ACSL4-dependent lipid metabolic reprogramming.

• Alpha-Ketoglutarate in Metabolic Research

  2026-09-18

  Alpha-ketoglutarate, also called α-KGA, connects tricarboxylic acid cycle flux with carbon–nitrogen metabolism. Recent cholangiocarcinoma evidence links α-KGA accumulation to OXGR1–MAPK signaling and reduced macrophage antigen presentation, while product specifications support controlled use in metabolic and enzyme-focused research.

• MitMAB Workflow for Organoid Endocytosis Research

  2026-09-17

  MitMAB provides a practical mechanistic perturbation for testing dynamin-dependent uptake in polarity-aware intestinal organoid models. This workflow combines regional organoid biology, extracellular-vesicle uptake measurements, viability controls, and orthogonal validation rather than treating reduced fluorescence as definitive proof of pathway inhibition.

• AO/PI Staining Solution for Cell Decisions

  2026-09-17

  Discover how AO/PI Staining Solution uses fluorescent DNA dyes to strengthen live/dead cell discrimination in diabetic nephropathy research. This guide connects membrane-integrity measurements with mechanistic evidence while defining what the assay can—and cannot—prove.

• ZCL278: Selective Cdc42 Inhibitor Workflow

  2026-09-16

  ZCL278 is a selective Cdc42 inhibitor for connecting biochemical GTPase assays with cell-based studies of motility, neuronal morphology, and signaling. This workflow shows how to control solvent, timing, pathway readouts, and cross-domain interpretation while using kidney-fibrosis research as a mechanistic guide rather than an unsupported therapeutic claim.

• Dynasore for Dynamin-Dependent Endocytosis

  2026-09-16

  Use Dynasore as a reversible dynamin GTPase inhibitor to test whether cargo uptake, vesicle recycling, or receptor trafficking depends on dynamin-mediated membrane fission. Its greatest value emerges when paired with nanoparticle size, surface-chemistry, viability, and orthogonal pathway controls rather than used as a stand-alone pathway label.

• Targeted NAC Nanoparticles Suppress OA Ferroptosis

  2026-09-15

  This study develops chondroitin sulfate-modified PLGA nanoparticles that deliver N-acetylcysteine to chondrocytes and protect cartilage by preserving glutathione-dependent GPX4 activity. In vitro and murine osteoarthritis experiments show improved redox control, reduced ferroptosis, stronger joint retention, and better cartilage preservation than free NAC or nontargeted nanoparticles.

• Stiripentol: LDH Inhibition for Metabolic Research

  2026-09-15

  Stiripentol gives researchers a chemical route to interrogate LDH-dependent lactate and pyruvate flux in epilepsy, neuronal metabolism, and tumor immunometabolism. This guide connects practical assay design with a 2025 study linking MPC-regulated lactate production to histone lactylation and dendritic-cell function.

• Direct Mouse Genotyping Kit Plus: From Allele to Assay

  2026-09-14

  The Direct Mouse Genotyping Kit Plus enables rapid, purification-free PCR for mouse genotyping. This article presents a decision framework linking genotype quality control to mechanistic studies of EP4, CD36, macrophage polarization, and atherosclerosis.

7917 records 1/528 page Next 12345 下5页 Last page